MyFinsight
Home
Blog
About
Back
Income Statement
Compass Therapeutics, Inc. (CMPX)
Compass Therapeutics, Inc. (CMPX)
source: myfinsight.com
Comprehensive loss
-$25,246,000
(-27.10%↓ Y/Y)
Net loss
-$25,154,000
(-26.52%↓ Y/Y)
Unrealized (gain) loss on
marketable securities
-$92,000
(-611.11%↓ Y/Y)
Interest income
$1,825,000
(54.01%↑ Y/Y)
Loss from operations
-$26,979,000
(-28.07%↓ Y/Y)
Total operating
expenses
$26,979,000
(28.07%↑ Y/Y)
Research and development
$19,576,000
(19.26%↑ Y/Y)
General and
administrative
$7,403,000
(59.17%↑ Y/Y)
Back